19 Jan 2010-20 Jan 2010 — London, UK
Over 8 years BioBusiness has brought together over 2500 business development professionals and CEOs from pharma and biotech as well as key healthcare investors.
Sona Khagram email: sona.khagram@wbr.co.uk phone: +44 (0) 207 368 9465
| 1,499 - £2,299 |
Tower Guoman, London.
The Premier Global Bio-Partnering Event
Over 8 years BioBusiness has brought together over 2500 business development professionals and CEOs from pharma and biotech as well as key healthcare investors. BioBusiness 2009 showcased deals and experts from leading pharma such as GLAXOSMITHKLINE, MERCK, BAYER SCHERING, PFIZER and ASTELLAS. With generics threatening pipelines and M&A at every scale high on industry agendas, delegates left with the contacts they needed to ensure essential business relationships and deals which will deliver success in 2009. With a speaker faculty reading like a who's who of pharma partnering, BioBusiness 2010 is consolidating its place as the most senior-level and effective partnering event in Europe. As the recession bites, both pharma and biotech are having to make tough choices about the events which will yield the best results for their organizations. That's why we've made BioBusiness and easy choice for you.
With a speaker faculty reading like a who's who of pharma partnering, BioBusiness 2010 is consolidating its place as the most senior-level and effective partnering event in Europe. Top confirmed speakers include Dan Zabrowski, Head of Worldwide Licensing from Roche, Tony Rosenberg, SVP BD&L from Novartis, Yetunde Taiwo, Senior Director, Global External R&D from Eli Lilly and many more! To register visit www.biobusiness-conference.com, call +44 (0) 207 368 9465 or email biobusiness@wbr.co.uk
BioBusiness 2010
The Premier Global Bio-Partnering Event
19th-20th January 2010, Guoman Tower, London
www.biobusiness-conference.com
With a speaker faculty reading like a who's who of pharma partnering, BioBusiness 2010 is consolidating its place as the most senior-level and effective partnering event in Europe. As the recession bites, both pharma and biotech are having to make tough choices about the events which will yield the best results for their organizations. That's why we've made BioBusiness and easy choice for you:
1. The most senior speaker line-up in Europe. Where else could you hear from (and meet with) the most senior speakers from top 10 pharma? Sign up now to make sure you're at this top-level gathering
2. Even more effective informal networking. BioBusiness attendees come back year after year because they know they'll have more opportunities to meet with their senior-level partners than anywhere else. Catch up with colleagues over coffee and make new contacts over dinner
3. The BioBusiness Agenda. We control the content of the BioBusiness agenda to ensure it add maximum value to your time at the conference. With high-level panel discussions, case studies and insights, you'll have to plan your networking carefully to take it all in!
4. We cap the number of attendees at BioBusiness to ensure the event remains intimate and effective for networking. No one wants to spend their days fighting through crowds of irrelevant people and BioBusiness cuts them out to help you ensure all your conversations have a business goal in mind.
5. We've reviewed our 1-2-1 technology to make it even more effective this year. Make sure you book up your meetings before the conference so you can arrive with your most critical meetings already lined up.
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
